Print

DUSA Pharmaceuticals (DUSA) to Present at the Rodman & Renshaw 14th Annual Healthcare Conference  
9/4/2012 9:30:42 AM

WILMINGTON, Mass., Sept. 4, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT), announced that Bob Doman, President and Chief Executive Officer, will present a corporate overview at the Rodman & Renshaw 14th Annual Healthcare Conference on Monday, September 10, 2012 at 11:15 a.m. ET at The Waldorf Astoria Hotel in New York City.
//-->